CLINICAL_TRIALS
trial_result
· 2018-11-20
Clinical Trial Update: Staccato Loxapine Single Dose PK [Phase 1]
Summary
Phase 1 PK update for single-dose Staccato Loxapine in schizophrenia; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2018-11-20